Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Data Analysis and Physical Function Evaluation Index Development for Early Diagnosis and Monitoring of ICU-acquired Weakness
- Conditions
- Cohort StudiesICU Acquired Weakness (ICUAW)Critical Illness
- First Posted Date
- 2024-11-01
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 51
- Registration Number
- NCT06669494
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Selinexor With ICE Chemotherapy in Secondary Central Nervous System Involving B-cell Non-Hodgkin Lymphoma
Phase 1
Recruiting
- Conditions
- B-cell Lymphoma RecurrentB-cell Lymphoma RefractoryCNS Metastases
- Interventions
- First Posted Date
- 2024-08-14
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 37
- Registration Number
- NCT06552559
- Locations
- 🇰🇷
Samsung Cancer Research Institute, Seoul, Korea, Republic of
🇰🇷Samsung Medical Center, Seoul, Korea, Republic of
Glofitamab in Relapsed or Refractory Diffuse Large B-cell Lymphoma After CD19 Chimeric Antigen Receptor T-cell Therapy
- First Posted Date
- 2024-08-14
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT06552572
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Individualized Automatic Target Coaching Message for Glycemic Management and Depressive Symptom
Not Applicable
Completed
- Conditions
- Diabetes Mellitus, Type 1
- Interventions
- Behavioral: Personalized coaching messages for blood glucose and emotions
- First Posted Date
- 2024-07-29
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 18
- Registration Number
- NCT06525454
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Usability Evaluation of a Mindfulness-based Serious Game
Not Applicable
Completed
- Conditions
- Pain, Chronic
- Interventions
- Other: mindfulness-based serious games
- First Posted Date
- 2024-07-26
- Last Posted Date
- 2024-07-26
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 19
- Registration Number
- NCT06522425
- Locations
- 🇰🇷
Samsung Medical Centre, Seoul, Korea, Republic of
Comparison of Conventional and Hypofractionated IMRT in High-Risk Cervical Cancer Post-Radical Hysterectomy
Phase 3
Recruiting
- Conditions
- Uterine Cervical Neoplasms
- Interventions
- Radiation: Hypofractionated IMRTRadiation: Conventional Fractionated IMRT
- First Posted Date
- 2024-07-19
- Last Posted Date
- 2024-07-26
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 248
- Registration Number
- NCT06509724
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Gangnam-gu, Korea, Republic of
Effects of Augmented Reality-based Rapid Blood Transfusion (Level-1®)
Not Applicable
Completed
- Conditions
- Equipment and SuppliesAugmented RealityNurse's Role
- Interventions
- Other: Traditional Guideline-based Self-LearningOther: AR-based Training with Microsoft HoloLens 2®
- First Posted Date
- 2024-07-18
- Last Posted Date
- 2024-07-18
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 42
- Registration Number
- NCT06506851
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
A Clinical Study for Developing Artificial Intelligence(AI)-Based Clustering Model for Personalized Medicine in Acute Respiratory Failure
Recruiting
- Conditions
- Acute Respiratory Failure
- First Posted Date
- 2024-06-28
- Last Posted Date
- 2024-06-28
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 250
- Registration Number
- NCT06479421
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Gangnam, Korea, Republic of
Systemic Treatment Alone Versus Systemic Treatment Plus Radiotherapy in Oligometastatic Renal Cell Carcinoma
Phase 3
Recruiting
- Conditions
- Kidney Neoplasm
- Interventions
- Radiation: SBRT(Stereotatic Body Radiation Therapy)
- First Posted Date
- 2024-06-20
- Last Posted Date
- 2024-06-20
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 88
- Registration Number
- NCT06467097
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy With SPACEOAR TM for Patients With Low-to-intermediate Risk Localized Prostate Cancer (DESAR-L)
Phase 2
Recruiting
- Conditions
- Low-to-intermediate-risk Prostate Carcinoma
- Interventions
- Radiation: Low- and medium-risk studies performed after biodegradable substance injection prostate cancer dose increase.
- First Posted Date
- 2024-06-17
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 33
- Registration Number
- NCT06461819
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath